ABSCIENCES (EPA:AB) | WebDisclosure

Basculer en Français

9478	Companies
185488	Keywords
117863	Articles
99343	Press releases

Home
Companies
ABSCIENCES

PRESS RELEASE

published on 10/11/2024 at 18:01, 1 year 1 month ago

Rapport financier semestriel 2024
PRESS RELEASE

published on 10/10/2024 at 11:55, 1 year 1 month ago

Rapport financier semestriel 2024
BRIEF

published on 10/10/2024 at 08:32, 1 year 1 month ago

AB Science Reports Mid-2024 Financial Results and Clinical Developments

Financial Results Clinical Trials Capital Increase AB Science Masitinib
BRIEF

published on 10/10/2024 at 08:32, 1 year 1 month ago

AB Science publie ses résultats financiers et ses développements cliniques pour la mi-2024

Résultats Financiers Augmentation De Capital Essais Cliniques Masitinib Sciences AB
PRESS RELEASE

published on 10/10/2024 at 08:27, 1 year 1 month ago

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities
AB Science presents financial results for the first half of 2024, updates on clinical development in ALS and MS, positive results in Covid-19 study, and intellectual property strengthening. AB announces capital increase and coverage initiations. Press Release by AB Science SA

Financial Results Capital Increase Clinical Development Intellectual Property AB Science
PRESS RELEASE

published on 10/10/2024 at 08:27, 1 year 1 month ago

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science
AB Science présente ses résultats financiers au premier semestre 2024 et les événements clés de la période, incluant le développement du masitinib, les résultats positifs dans la Covid-19 et le renforcement de la propriété intellectuelle

Résultats Financiers COVID-19 Développement Clinique AB Science Masitinib
BRIEF

published on 09/30/2024 at 08:34, 1 year 2 months ago

AB Science annonce une augmentation de capital de 5,0 millions d’euros

Augmentation De Capital Développement Clinique AB Science Masitinib Investisseurs Européens
BRIEF

published on 09/30/2024 at 08:34, 1 year 2 months ago

AB Science announces a capital increase of 5.0 million euros

Capital Increase Clinical Development AB Science Masitinib European Investors
PRESS RELEASE

published on 09/30/2024 at 08:29, 1 year 2 months ago

AB Science annonce une augmentation de capital de 5,0 millions d’euros
AB Science annonce avec succès une augmentation de capital de 5 millions d’euros par placement privé pour financer le développement clinique de AB8939

Placement Privé Augmentation De Capital Développement Clinique AB Science AB8939
BRIEF

published on 09/23/2024 at 17:56, 1 year 2 months ago

AB Science fait le point sur le développement du masitinib dans les formes progressives de sclérose en plaques

Sclérose En Plaques Traitement Masitinib ECTRIMS 2024 Neurodégénératif

Accesswire

Published on 12/05/2025 at 16:00, 11 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 26 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 26 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 36 minutes ago

XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:25, 46 minutes ago

Usha Resources Provides Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 16:00, 11 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 11 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 11 minutes ago

Amundi Physical Metals plc: Communiqué de Mise à Disposition du Rapport Financier Semestriel au 30 septembre 2025
Published on 12/05/2025 at 16:00, 11 minutes ago

Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 15:47, 23 minutes ago

Form 8.3 - The Vanguard Group, Inc.: NCC Group plc

Les Echos

Published on 12/05/2025 at 15:10, 1 hour ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 1 hour ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 2 hours 12 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 7 hours 26 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 7 hours 26 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry

View all LES ECHOS COMFI WIRE